MedRhythms, Inc.
PrivateLast Round
Seed Round
Jul 31, 2026
Total Funding Raised
$32.26M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MedRhythms, Inc. operates in Healthcare & Life Sciences and is based in Portland, Maine. Its latest recorded funding round was a Series B Extension round in November 2021.
MedRhythms, Inc. is a digital therapeutics company that develops neurorehabilitation solutions combining sensors, software, and music to improve walking and mobility for patients with neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B2C
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MedRhythms, Inc. Comparables
Compare MedRhythms, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neurofenix | 83% | |
| BrainQ Technologies | 80% | |
| Constant Therapy Health | 78% |
For institutional investors. Book with your work email.
MedRhythms, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jul 31, 2026 | ||||
| Seed Round | Feb 13, 2026 | ||||
| Series B Extension | Nov 16, 2021 | ||||
| Series B | Jul 28, 2021 | ||||
| Early Funding | Aug 8, 2019 | ||||
Series A | Jul 2, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MedRhythms, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bose Ventures | Series B Extension, Series B |
| Athenian Capital | Series B |
| Advantage Capital | Series B |
| Global Brain Corporation | Series B Extension, Series B |
| Morningside Ventures | Series B |
| Werth Family Investment Associates | Series B, Series A |
| Maine Venture Fund | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 84% MoM.
- Jul 31, 2026
$1M raised in Seed Round.
For institutional investors. Book with your work email.
MedRhythms, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MedRhythms, Inc.'s valuation, stock price, and market status.
Is MedRhythms, Inc. a public or private company?
MedRhythms, Inc. is a private company.
What is the current stock price of MedRhythms, Inc.?
MedRhythms, Inc. is a private company, so its shares have no public market price. Caplight tracks MedRhythms, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MedRhythms, Inc. worth (valuation)?
Valuation information for MedRhythms, Inc. is not publicly available.
Can I buy MedRhythms, Inc. stock?
MedRhythms, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MedRhythms, Inc.'s last funding round?
MedRhythms, Inc.'s most recent funding round was Seed Round on July 31, 2026.
Who are the main investors in MedRhythms, Inc.?
Key investors in MedRhythms, Inc. include Advantage Capital, Morningside Ventures, Werth Family Investment Associates.
Will MedRhythms, Inc. IPO soon?
No public IPO plans have been announced for MedRhythms, Inc..
How can I track MedRhythms, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in MedRhythms, Inc.'s shares on secondary markets.